Dr. Alexandra Perez has worked for the past 13 years in the area of pharmaceutical outcomes research. She received her PharmD from Nova Southeastern University and completed an MS in Pharmacy Administration, pharmacy practice residency, and fellowship in Pharmacoeconomics and Outcomes Research at the University of Illinois at Chicago. She has worked as a faculty at Nova Southeastern University College of Pharmacy since 2008 and is currently an associate professor and associate chair in the Sociobehavioral and administrative pharmacy department. She recently completed a faculty fellowship in patient-centered outcomes research (PCOR) as part of an Agency for Healthcare and Research Quality (AHRQ)-funded grant at the University of Pittsburgh and completed a professional certificate in data science at the University of Puerto Rico.

Dr. Perez is currently a principal investigator in an internal grant that seeks to compare the effectiveness of dual versus triple antihyperglycemic regimens in cardiovascular and renal outcomes using a very large database of electronic medical records from UPMC (formerly known as the University of Pittsburgh Medical Center). In terms of collaborative research, Dr. Perez has published over 20 manuscripts and book chapters and delivered over 50 poster and podium presentations in national and international conferences. In her pharmacoepidemiologic studies, she has demonstrated that medication regimens for secondary prevention of morbidity and mortality of diabetes are not optimal. Her work has also shown that racial/ethnic disparities in the management of patients with diabetes exist. These studies were developed using the National Health and Nutrition Examination Survey (NHANES). Finally, she has demonstrated the clinical effectiveness and economic value of clinical pharmacy services among patients with diabetes, cardiovascular and other diseases through retrospective studies and systematic reviews. Recently, Dr. Perez has gained expertise in using the National Ambulatory Medical Care Survey (NAMCS) to evaluate the trends in use of opioids among adult patients admitted to the emergency department for kidney stones.

Dr. Perez has extensive experience teaching pharmacoeconomics, data analytics, and other research topics in core and elective professional and graduate courses. She is a PhD advisor, has served in several dissertation committees, and has served as a senior research mentor in many residency projects.

At the College of Pharmacy level, Dr. Perez has served as a chairperson (5 years) and member of the Admissions Committee and has also served in the Assessment and Continuing Contract and Promotions committees. At the University level, she was nominated and serves as a member of the Faculty Advisory Council. Nationally, she has represented the College as a national delegate at the American Association of Colleges of Pharmacy (AACP) Midyear and Annual meetings, is a member of the NIH/NIDDK Network of Minority Research Investigators (NMRI), and a steering committee member in the ENACT Network based out of the University of Pittsburgh. She is also a member of the Rho Chi pharmacy honor society, Phi Lambda Sigma pharmacy leadership society, the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), and AACP.

Click here for most up to date list of publications (My PubMed Bibliography)